Kras/ADAM17-Dependent Jag1-ICD Reverse Signaling Sustains Colorectal Cancer Progression and Chemoresistance.
ADAM17 Protein
/ genetics
Animals
Carcinogenesis
/ genetics
Cell Line, Tumor
Colorectal Neoplasms
/ genetics
Disease Progression
Drug Resistance, Neoplasm
/ genetics
Epithelial-Mesenchymal Transition
/ genetics
Female
HCT116 Cells
HT29 Cells
Humans
Jagged-1 Protein
/ genetics
Mice
Mice, Nude
Neoplasm Recurrence, Local
/ genetics
Proto-Oncogene Proteins p21(ras)
/ genetics
Signal Transduction
/ genetics
Journal
Cancer research
ISSN: 1538-7445
Titre abrégé: Cancer Res
Pays: United States
ID NLM: 2984705R
Informations de publication
Date de publication:
01 Nov 2019
01 Nov 2019
Historique:
received:
11
01
2019
revised:
17
05
2019
accepted:
06
09
2019
pubmed:
12
9
2019
medline:
29
5
2020
entrez:
12
9
2019
Statut:
ppublish
Résumé
Colorectal cancer is characterized by well-known genetic defects and approximately 50% of cases harbor oncogenic
Identifiants
pubmed: 31506332
pii: 0008-5472.CAN-19-0145
doi: 10.1158/0008-5472.CAN-19-0145
doi:
Substances chimiques
JAG1 protein, human
0
Jagged-1 Protein
0
KRAS protein, human
0
ADAM17 Protein
EC 3.4.24.86
ADAM17 protein, human
EC 3.4.24.86
Proto-Oncogene Proteins p21(ras)
EC 3.6.5.2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
5575-5586Informations de copyright
©2019 American Association for Cancer Research.